Benjamin D. Margolis

Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients

Steven A. Conrad, Andrea Gabrielli, Benjamin D. Margolis et al. · Critical Care Medicine · 2005 · 162 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +8

Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US)

Gordon R. Bernard, Benjamin D. Margolis, Harvey M. Shanies et al. · CHEST Journal · 2004 · 162 citations

Medicine, Immunology, Pharmacology +4

Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis

S. Betty Yan, Benjamin D. Margolis, José A. Lorente et al. · Thrombosis and Haemostasis · 2003 · 121 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Phase 2 Randomized, Double-Blind, Placebo–Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis*

Kalpalatha K. Guntupalli, Nathan C. Dean, Peter E. Morris et al. · Critical Care Medicine · 2013 · 73 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +16

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Peter Pickkers, Derek C. Angus, Kristie Bass et al. · Intensive Care Medicine · 2024 · 67 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16